SILEXION THERAPEUTICS CORP (SLXN) is held by institutional investors who disclose positions via SEC 13F filings. View the full list of institutional holders on HoldingsIntel.

Are institutions buying or selling SLXN?

HoldingsIntel tracks quarter-over-quarter changes in institutional positions for SILEXION THERAPEUTICS CORP, showing new buyers, position increases, decreases, and exits with conviction-weighted sentiment.

What is the Smart Money Verdict on SLXN?

The Smart Money Verdict combines four independent signals (institutional 13F activity, insider trades, activist filings, and congressional trades) into a single assessment for SILEXION THERAPEUTICS CORP.

Is institutional money flowing into SLXN?

3 institutional investors hold SILEXION THERAPEUTICS CORP (SLXN). View detailed buyer/seller breakdown on HoldingsIntel.

What do hedge funds think about SLXN?

Track institutional sentiment and conviction scores for SILEXION THERAPEUTICS CORP (SLXN) including Smart Money Verdict and position changes on HoldingsIntel.

Fund	Action	Shares	Value	Weight	Est. P&L	Conviction
CITADEL ADVISORS LLC	Increased	20,926(+71.5%)	$26,785	0.0%	-82.95%	20
UBS Group AG	Decreased	517(-69.4%)	$662	0.0%	-95.83%	0
JONES FINANCIAL COMPANIES LLLP	Unchanged	26	$32	0.0%	-83.24%	0

SILEXION THERAPEUTICS CORP

Continue exploring

Other Healthcare stocks held by institutions

SILEXION THERAPEUTICS CORP

Continue exploring

Other Healthcare stocks held by institutions